Page 13 - Demo

13%u2022 Calcirol: The world%u2019s first injectable form of Vitamin D.%u2022 Polycap: A pioneering five-in-one pill to prevent cardiovascular disease.%u2022 Mycidac-C: The world%u2019s first active immunotherapy for lung cancer.%u2022 ThRabis: The world%u2019s first three-dose rabies vaccine, changing the global fight against rabies.Today, Cadila operates in more than 100 countries, employs over 9,000 professionals, and runs 10 manufacturing sites and five R&D centers, a scale unimaginable at its inception but always aligned with its founder%u2019s vision.The USPsBecause of its distinctive fusion of ethics, innovation, and accessibility, Cadila stands out in the prestigious pharmaceutical sector. They have introduced world-first products instead of replicating existing treatments, and consistently demonstrated an innovationfirst mentality. At the same time, it has made healthcare more affordable and accessible, ensuring that even rural communities and underserved markets can access high-quality care. However, what truly distinguishes Cadila is its commitment to moral and valuesbased development, wherein monetary gain is never pursued at the price of community well-being or patient safety. Owing to this unique set of three guiding principles, Cadila has made a name for itself as a company that adeptly blends scientific leadership with deep social responsibility.